Literature DB >> 8306100

Effects of selective antagonism of beta-adrenoceptor sub-types on responses to isoprenaline in rat distal colon in vitro.

A MacDonald1, M Lamont.   

Abstract

1. The effects of the beta 1- and beta 2-adrenoceptor selective antagonists, CGP 20712A and ICI 118551 respectively, on responses to isoprenaline-induced relaxation of rat distal colon were investigated in order to determine the contributions of these subtypes to relaxation. In addition, the properties of ICI D7114, a novel putative stimulant of atypical beta-adrenoceptors, were investigated. Our preliminary experiments with ICI D7114 showed that this compound lacked agonist activity in rat distal colon and in fact antagonized responses to isoprenaline. We therefore studied the antagonism of isoprenaline by ICI D7114 in more detail. 2. Longitudinal segments of rat distal colon were suspended in Krebs solution at 37 degrees C for isometric recording. The Krebs solution contained EDTA (23 microM) and prazosin (0.1 microM) and was gassed with 95/5% O2/CO2. After an initial equilibration period, reproducible contractions to a submaximal concentration of methacholine (1 microM) were obtained before carrying out a concentration-response curve (CRC) to isoprenaline in a non-cumulative manner. Four consecutive CRCs to isoprenaline were carried out in each tissue with a 1 h interval between each curve. Antagonists were present in increasing concentrations during the intervals between CRCs. Control tissues received no antagonists to allow estimation of the magnitude of time-dependent changes. 3. Isoprenaline produced a concentration-dependent inhibition of methacholine-induced contractions. CRCs to isoprenaline were reproducible with no significant time-dependent changes. Propranolol produced no shift of the isoprenaline CRC at 0.01 microM and a 5 fold shift at 0.1 microM. No further shift was observed with 1 microM. CGP 20712A had no effect on the CRC to isoprenaline at 0.1, 1 and 3 microM. ICI118551 produced little or no shift at 0.1 microM and a six fold shift with 1 microM. No further shift was observed with 3 microM. ICI D7114 produced a concentration-dependent parallel rightward shift of the CRC to isoprenaline. Schild analysis gave a slope close to unity and a mean pA2 value of 7.29 for ICI D7114.4. The results with propranolol and ,l- and 132-adrenoceptor antagonists confirm the mainly atypical nature of beta-adrenoceptors in rat distal colon. There may also be a small contribution from beta2-adrenoceptors in the response to isoprenaline but beta1-adrenoceptors are absent. ICI D7114 has no agonist activity and behaves as a relatively high affinity reversible competitive antagonist of atypical beta-adrenoceptors in this preparation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8306100      PMCID: PMC2175883          DOI: 10.1111/j.1476-5381.1993.tb14000.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  15 in total

1.  Agonist and antagonist characterization of a putative adrenoceptor with distinct pharmacological properties from the alpha- and beta-subtypes.

Authors:  R A Bond; D E Clarke
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

Review 2.  Is the adipocyte beta-adrenoceptor a prototype for the recently cloned atypical 'beta 3-adrenoceptor'?

Authors:  J Zaagsma; S R Nahorski
Journal:  Trends Pharmacol Sci       Date:  1990-01       Impact factor: 14.819

3.  How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?

Authors:  D MacKay
Journal:  J Pharm Pharmacol       Date:  1978-05       Impact factor: 3.765

4.  Pharmacological characterization of the postjunctional beta-adrenoceptors in the rat gastric fundus.

Authors:  R A Lefebvre; P A Verplanken; M G Bogaert
Journal:  Eur J Pharmacol       Date:  1984-10-30       Impact factor: 4.432

5.  Evidence that ICI 118, 551 is a potent, highly Beta 2-selective adrenoceptor antagonist and can be used to characterize Beta-adrenoceptor populations in tissues.

Authors:  S R O'Donnell; J C Wanstall
Journal:  Life Sci       Date:  1980-08-25       Impact factor: 5.037

6.  CGP 20712 A: a useful tool for quantitating beta 1- and beta 2-adrenoceptors.

Authors:  D J Dooley; H Bittiger; N C Reymann
Journal:  Eur J Pharmacol       Date:  1986-10-14       Impact factor: 4.432

7.  Differentiation of receptor systems activated by sympathomimetic amines.

Authors:  A M Lands; A Arnold; J P McAuliff; F P Luduena; T G Brown
Journal:  Nature       Date:  1967-05-06       Impact factor: 49.962

8.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

9.  The rat lipolytic beta-adrenoceptor: studies using novel beta-adrenoceptor agonists.

Authors:  C Wilson; S Wilson; V Piercy; M V Sennitt; J R Arch
Journal:  Eur J Pharmacol       Date:  1984-05-04       Impact factor: 4.432

10.  Adrenergic receptor-mediated response of the rabbit small and large intestine.

Authors:  M K Sim; J M Lim
Journal:  Jpn J Pharmacol       Date:  1983-04
View more
  4 in total

1.  beta(1)-Adrenoceptors compensate for beta(3)-adrenoceptors in ileum from beta(3)-adrenoceptor knock-out mice.

Authors:  D S Hutchinson; B A Evans; R J Summers
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

2.  Characterization of beta-adrenoceptor mediated smooth muscle relaxation and the detection of mRNA for beta1-, beta2- and beta3-adrenoceptors in rat ileum.

Authors:  S J Roberts; M Papaioannou; B A Evans; R J Summers
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

3.  Atypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.

Authors:  A Hoey; C Jackson; G Pegg; M Sillence
Journal:  Br J Pharmacol       Date:  1996-02       Impact factor: 8.739

4.  Inhibitory effects of SR 58611A on canine colonic motility: evidence for a role of beta 3-adrenoceptors.

Authors:  F De Ponti; M Cosentino; A Costa; M Girani; G Gibelli; L D'Angelo; G Frigo; A Crema
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.